Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

6.15
-0.4150-6.33%
Post-market: 6.09-0.0550-0.90%19:34 EDT
Volume:247.52K
Turnover:1.60M
Market Cap:3.69M
PE:-0.06
High:6.87
Open:6.56
Low:6.07
Close:6.56
52wk High:80.70
52wk Low:4.56
Shares:600.70K
Float Shares:593.10K
Volume Ratio:1.14
T/O Rate:41.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:0.98
PE(LYR):-0.05

Loading ...

bioAffinity Technologies Partners with AvMEDICAL to Distribute CyPath Lung Test Across Federal Healthcare Market

Reuters
·
Sep 30

BioAffinity to present clinical, veteran-focused data on CyPath Lung

TIPRANKS
·
Sep 22

bioAffinity Launches 2,000-Patient FlowPath Lung Study Testing CyPath Lung in Veteran, Military Populations

Reuters
·
Sep 22

Top Midday Gainers

MT Newswires Live
·
Sep 18

bioAffinity Technologies Inc trading halted, volatility trading pause

TIPRANKS
·
Sep 18

BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung

TIPRANKS
·
Sep 17

bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's Cypath® Lung Noninvasive Lung Cancer Diagnostic

THOMSON REUTERS
·
Sep 17

bioAffinity Technologies - Cypath Lung Receives Dual Patent Protection in Hong Kong and China

THOMSON REUTERS
·
Sep 17

BioAffinity Technologies regains compliance with Nasdaq listing requirements

TIPRANKS
·
Sep 09

bioAffinity Technologies Regains Compliance with NASDAQ Listing Requirements

THOMSON REUTERS
·
Sep 09

bioAffinity Technologies Inc trading halted, volatility trading pause

TIPRANKS
·
Sep 04

NASDAQ Trade Halt Volatility Trading Pause at 11:06 Am

Reuters
·
Sep 04

bioAffinity CEO to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 04

U.S. Stocks on the MOVE-FuelCell, Gold Miners, NetApp

Reuters
·
Sep 03

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Sep 01

BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance

TIPRANKS
·
Sep 01

bioAffinity Advances CyPath Lung Test for Post-Treatment Lung Cancer Surveillance

Reuters
·
Sep 01

bioAffinity Technologies Advances Cypath® Lung for Surveillance of Lung Cancer Survivors

THOMSON REUTERS
·
Sep 01

NASDAQ Trade Halt Continues Reason not Available at 03:58 Am

Reuters
·
Aug 24

bioAffinity Technologies Inc trading halted, news pending

TIPRANKS
·
Aug 22